4162 Share Price Performance
NT$72.60
-19.90 (-21.51%)
Price NT$72.60
Share Pricen/a
PharmaEngine, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
4162 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Outstanding track record with flawless balance sheet and pays a dividend.
2 Risks
3 Rewards
PharmaEngine, Inc. Key Details
About 4162
- Founded
- 2002
- Employees
- 44
- CEO
- WebsiteView website
PharmaEngine, Inc., a biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan. It offers ONIVYDE, a cancer medicine that blocks an enzyme called topoisomerase I, which is involved in copying cell DNA needed to make new cells. The company is developing PEP07, a CHK1 inhibitor, which is in Phase 1 clinical trial for the treatment of hematological tumors and solid tumors. PharmaEngine, Inc. was incorporated in 2002 and is headquartered in Taipei, Taiwan.
